---
figid: PMC11655944__12672_2024_1624_Fig2_HTML
figtitle: Antitumor effects mechanism of EH
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11655944
filename: 12672_2024_1624_Fig2_HTML.jpg
figlink: /pmc/articles/PMC11655944/figure/F2/
number: F2
caption: Antitumor effects mechanism of EH. A. EH can inhibit the growth of cervical
  cancer cells by increasing antioxidant capacity, promoting apoptosis, and inducing
  cycle blockade. B. EH can inhibit hepatocellular carcinoma cell growth by inhibiting
  angiogenesis, apoptosis, and anti-inflammatory response. C. EH can inhibit intestinal
  cancer cell growth by activating STAT3, circRHOT1/miR-29a-3p signalling pathway
papertitle: Research progress on the anti-tumor effects of euphorbia humifusa
reftext: Xiaoxue Zhao, et al. Discov Oncol. 2024 Dec;15(NA).
year: '2024'
doi: 10.1007/s12672-024-01624-7
journal_title: Discover Oncology
journal_nlm_ta: Discov Oncol
publisher_name: Springer
keywords: Euphorbia humifusae | Antitumor | Chemical constituents | Pharmacological
  effects
automl_pathway: 0.9446054
figid_alias: PMC11655944__F2
figtype: Figure
redirect_from: /figures/PMC11655944__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11655944__12672_2024_1624_Fig2_HTML.html
  '@type': Dataset
  description: Antitumor effects mechanism of EH. A. EH can inhibit the growth of
    cervical cancer cells by increasing antioxidant capacity, promoting apoptosis,
    and inducing cycle blockade. B. EH can inhibit hepatocellular carcinoma cell growth
    by inhibiting angiogenesis, apoptosis, and anti-inflammatory response. C. EH can
    inhibit intestinal cancer cell growth by activating STAT3, circRHOT1/miR-29a-3p
    signalling pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CDKN2A
  - SOD1
  - SOD2
  - SOD3
  - PCYT1A
  - CERNA3
  - H3P10
  - CCND1
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - MMP9
  - IL6
  - IL17A
  - TLR4
  - IL1B
  - STAT3
  - DDIT3
  - XBP1
  - XBP1P1
  - ATF4
  - BCL2
  - BAX
  - CHMP2A
  - IL2
  - TNF
  - PECAM1
  - MYC
  - PDGFB
  - MMP2
  - cancer
---
